Factors associated with acquisition of Pseudomonas aeruginosa resistant to gentamicin

Insights

Gentamicin-resistant Pseudomonas aeruginosa infections are linked to prior antibiotic use. Patients with resistant strains had more antibiotic exposure, especially gentamicin, compared to those with sensitive strains.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Rising occurrence of gentamicin-resistant Pseudomonas aeruginosa infections.
  • Need to understand risk factors associated with resistant strains.

Purpose of the Study:

  • To investigate the clinical characteristics and risk factors for gentamicin-resistant Pseudomonas aeruginosa infections.
  • To compare patients with resistant strains to those with sensitive strains.

Main Methods:

  • Retrospective review of Pseudomonas aeruginosa isolates from 1974-1975.
  • Comparison of patients with gentamicin-resistant versus gentamicin-sensitive P. aeruginosa infections.
  • Analysis of prior antibiotic therapy and exposure to multiple antibiotics.

Main Results:

  • 39 patients had gentamicin-resistant P. aeruginosa; 683 had gentamicin-sensitive strains.
  • Patients with resistant infections showed higher rates of prior antibiotic therapy (p<0.01).
  • Prior gentamicin therapy (p<0.005) and exposure to multiple antibiotics were also more common in resistant cases.

Conclusions:

  • Prior antibiotic exposure, particularly to gentamicin, is a significant risk factor for gentamicin-resistant Pseudomonas aeruginosa infections.
  • The findings highlight the importance of antibiotic stewardship in preventing the emergence of resistant pathogens.
  • Further research is needed to explore resistance mechanisms and optimal treatment strategies.

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...